J1810 – Injection, droperidol and fentanyl citrate, up to 2 ml ampule
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1810
- Long description
- Injection, droperidol and fentanyl citrate, up to 2 ml ampule
- Short description
- Droperidol/fentanyl inj
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 1982
- Last change
- April 1, 2025 – No change
- Termination date
- March 31, 2025
Frequently asked questions
What is HCPCS code J1810?
J1810 is a HCPCS Level II code for injection, droperidol and fentanyl citrate, up to 2 ml ampule. It was discontinued on March 31, 2025.
Does Medicare cover J1810?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1786 – Injection, imiglucerase, 10 units
- J1790 – Injection, droperidol, up to 5 mg
- J1800 – Injection, propranolol hcl, up to 1 mg
- J1805 – Injection, esmolol hydrochloride, 10 mg
- J1806 – Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
- J1807 – Injection, ethacrynate sodium, 1 mg
- J1808 – Injection, folic acid, 0.1 mg
- J1809 – Injection, fosdenopterin, 0.1 mg
- J1811 – Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
- J1812 – Insulin (fiasp), per 5 units
- J1813 – Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
- J1814 – Insulin (lyumjev), per 5 units
- J1815 – Injection, insulin, per 5 units
- J1817 – Insulin for administration through dme (i.e., insulin pump) per 50 units
- J1818 – Injection, pegzilarginase-nbln, 0.05 mg
- J1823 – Injection, inebilizumab-cdon, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.